ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 413

A Multiple Cause-Of-Death Study In Rheumatoid Arthritis

Frederico A. G. Pinheiro1, Deborah C. C. Souza1 and Emilia I. Sato2, 1Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 2Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: death, rheumatoid arthritis (RA) and statistics

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) is the most common chronic inflammatory arthritis and has a high standardized mortality ratio when compared to general population. One of the possible ways to assessing mortality is to use the death certificate (DC) that is nationally available and has a broad coverage and further continuity. The evaluation of multiple cause-of-deaths provides beyond the underlying cause of death, the understanding of whole context of death, by the recognition of non-underlying causes of death, which are very important in chronic diseases. The aim of study was to evaluate the mortality profile of RA using the multiple cause-of-death method.

Methods:

The DC is established according to World Health Organization recommendation and is composed by two parts: the first presents the sequence of events leading to death, with underlying cause of death stated at last line, and the second part is composed by contributing causes of death.

Death information was provided by the state public center responsible to receive the data from civil registry office. The data about the whole population were obtained from the site of public health care system. Were chosen DC which has had RA (ICD-10: all group M05, M06.1, M06.8 and M06.9) on any line of the medical certification. All DC (N=3938) age above 19 years, for the period of 1996 to 2010 on which RA was listed as an underlying (N=1091) or non-underlying (N=2847) cause of death were analyzed. The variables gender, age and cause of death were analyzed, as well as comparisons between the two sub-periods (1996 -2000 and 2006-2010).  To compare the proportional mention of causes of death between the sub-periods, we used chi-square test, performed at SPSS version 20.0. We set the level of significance at p < 0.05.

Results:

For RA as an underlying cause of death, 251 were males (M) and 840 females (F), with a ratio M/F of 1/3.3. The mean age of death was 67.12 (SD 13.32) years and the main non-underlying causes of death associated with RA were pneumonia (38.86%), septicemia (29.7%), interstitial lung disease (10.91%) and heart failure (9.17%). Comparing the sub-periods, there was an increase of infectious causes (pneumonia and septicemia) and a reduction of heart failure, while interstitial lung disease remained stable. 

For RA as a non-underlying cause of death, the mean age of death was 67.92 (SD 13.03) years, with 672 males and 2175 females and a sex ratio of 1/3.2. The most common underlying causes of death were circulatory (35.16%) and respiratory system diseases (21.81%). Comparing the two sub-periods, there was a decrease in respiratory system (all group), pneumonia and cerebral infarction, but an increase in interstitial lung disease in more recent period.

There were 19 cases of tuberculosis (3 as non-underlying and 16 as underlying cause-of-death), but without any type of predominance.

Conclusion:

The cardiovascular (CV) disease remains as an important cause of death in RA, justifying a judicious follow-up and treatment of CV risk factors. The infectious diseases are an increasing cause of death in RA patients, bringing the question if infection is related with the vigorous immunosuppressive treatment.


Disclosure:

F. A. G. Pinheiro,
None;

D. C. C. Souza,
None;

E. I. Sato,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-multiple-cause-of-death-study-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology